IOVANCE BIOTHERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$4.44 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$5.91M, a 185.81% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $1.47M, a 54.91% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $661.00K, a 87.57% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$2.78M, a 212.30% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $8.02M, a 279.70% increase from fiscal 2024.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $2.11M, a 79.00% decline from fiscal 2023.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $10.06M, a 372.39% increase from fiscal 2022.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $2.13M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 54 month | Increase (Decrease) in Prepaid Expense and Other Assets 57 month | Increase (Decrease) in Prepaid Expense and Other Assets 60 month | Increase (Decrease) in Prepaid Expense and Other Assets 63 month | Increase (Decrease) in Prepaid Expense and Other Assets 66 month | Increase (Decrease) in Prepaid Expense and Other Assets 69 month | Increase (Decrease) in Prepaid Expense and Other Assets 72 month | Increase (Decrease) in Prepaid Expense and Other Assets 78 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$4.44M 10-Q · filed 2026-08-06 | -$3.78M derived: sum of 3 quarters · filed 2026-08-06 | -$6.56M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||
| 2026-03-31 | $1.47M 10-Q · filed 2026-05-07 | $2.13M derived: sum of 2 quarters · filed 2026-05-07 | -$649.00K derived: sum of 3 quarters · filed 2026-05-07 | $6.24M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||
| 2025-12-31 | $661.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$2.12M derived: sum of 2 quarters · filed 2026-02-24 | $4.77M derived: sum of 3 quarters · filed 2026-08-06 | $8.02M 10-K · filed 2026-02-24 | ||||||||||||
| 2025-09-30 | -$2.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.11M derived: sum of 2 quarters · filed 2026-08-06 | $7.36M 10-Q · filed 2025-11-06 | $12.68M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||
| 2025-06-30 | $6.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $10.14M 10-Q · filed 2026-08-06 | $15.46M derived: sum of 3 quarters · filed 2026-08-06 | $17.93M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||
| 2025-03-31 | $3.25M 10-Q · filed 2026-05-07 | $8.57M derived: sum of 2 quarters · filed 2026-05-07 | $11.04M derived: sum of 3 quarters · filed 2026-05-07 | $11.25M derived: sum of 4 quarters · filed 2026-05-07 | ||||||||||||
| 2024-12-31 | $5.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $7.79M derived: sum of 2 quarters · filed 2026-02-24 | $8.00M derived: sum of 3 quarters · filed 2026-02-24 | $2.11M 10-K · filed 2026-02-24 | ||||||||||||
| 2024-09-30 | $2.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.68M derived: sum of 2 quarters · filed 2025-11-06 | -$3.21M 10-Q · filed 2025-11-06 | $1.94M derived: sum of 4 quarters · filed 2026-02-24 | ||||||||||||
| 2024-06-30 | $211.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$5.68M 10-Q · filed 2025-08-07 | -$529.00K derived: sum of 3 quarters · filed 2026-02-24 | -$2.68M derived: sum of 4 quarters · filed 2026-02-24 | ||||||||||||
| 2024-03-31 | -$5.89M 10-Q · filed 2025-05-08 | -$740.00K derived: sum of 2 quarters · filed 2026-02-24 | -$2.89M derived: sum of 3 quarters · filed 2026-02-24 | -$57.00K derived: sum of 4 quarters · filed 2026-02-24 | ||||||||||||
| 2023-12-31 | $5.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.00M derived: sum of 2 quarters · filed 2026-02-24 | $5.83M derived: sum of 3 quarters · filed 2026-02-24 | $10.06M 10-K · filed 2026-02-24 | ||||||||||||
| 2023-09-30 | -$2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $683.00K derived: sum of 2 quarters · filed 2024-11-07 | $4.91M 10-Q · filed 2024-11-07 | $2.07M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||
| 2023-06-30 | $2.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $7.07M 10-Q · filed 2024-08-08 | $4.22M derived: sum of 3 quarters · filed 2025-02-27 | $6.53M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||
| 2023-03-31 | $4.23M 10-Q · filed 2024-05-09 | $1.39M derived: sum of 2 quarters · filed 2025-02-27 | $3.70M derived: sum of 3 quarters · filed 2025-02-27 | $2.65M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||
| 2022-12-31 | -$2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$531.00K derived: sum of 2 quarters · filed 2025-02-27 | -$1.58M derived: sum of 3 quarters · filed 2025-02-27 | $2.13M 10-K · filed 2025-02-27 | ||||||||||||
| 2022-09-30 | $2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.26M derived: sum of 2 quarters · filed 2023-11-07 | $4.98M 10-Q · filed 2023-11-07 | $2.72M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2022-06-30 | -$1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $2.66M 10-Q · filed 2023-08-08 | $403.00K derived: sum of 3 quarters · filed 2024-02-28 | -$3.15M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2022-03-31 | $3.71M 10-Q · filed 2023-05-10 | $1.46M derived: sum of 2 quarters · filed 2024-02-28 | -$2.10M derived: sum of 3 quarters · filed 2024-02-28 | -$3.13M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2021-12-31 | -$2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$5.81M derived: sum of 2 quarters · filed 2024-02-28 | -$6.84M derived: sum of 3 quarters · filed 2024-02-28 | -$2.77M 10-K · filed 2024-02-28 | ||||||||||||
| 2021-09-30 | -$3.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$4.58M derived: sum of 2 quarters · filed 2022-11-03 | -$517.00K 10-Q · filed 2022-11-03 | -$11.99M 10-Q · filed 2021-11-04 | $6.24M derived: sum of 4 quarters · filed 2023-02-28 | |||||||||||
| 2021-06-30 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $3.04M 10-Q · filed 2022-08-04 | -$8.16M 10-Q · filed 2021-08-05 | $9.79M derived: sum of 3 quarters · filed 2023-02-28 | $8.66M derived: sum of 4 quarters · filed 2023-02-28 | |||||||||||
| 2021-03-31 | $4.07M 10-Q · filed 2022-05-05 | -$7.13M 10-Q · filed 2021-05-06 | $10.82M derived: sum of 2 quarters · filed 2023-02-28 | $9.69M derived: sum of 3 quarters · filed 2023-02-28 | $9.44M derived: sum of 4 quarters · filed 2023-02-28 | |||||||||||
| 2020-12-31 | $6.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $5.62M derived: sum of 2 quarters · filed 2023-02-28 | $5.37M derived: sum of 3 quarters · filed 2023-02-28 | $6.69M 10-K · filed 2023-02-28 | ||||||||||||
| 2020-09-30 | -$1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$1.38M derived: sum of 2 quarters · filed 2021-11-04 | -$66.00K 10-Q · filed 2021-11-04 | $4.00M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||||||
| 2020-06-30 | -$252.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.06M 10-Q · filed 2021-08-05 | $5.13M derived: sum of 3 quarters · filed 2022-02-24 | $3.83M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||||||
| 2020-03-31 | $1.32M 10-Q · filed 2021-05-06 | $5.38M derived: sum of 2 quarters · filed 2022-02-24 | $4.08M derived: sum of 3 quarters · filed 2022-02-24 | $6.19M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||||||
| 2019-12-31 | $4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.76M derived: sum of 2 quarters · filed 2022-02-24 | $4.87M derived: sum of 3 quarters · filed 2022-02-24 | $3.28M 10-K · filed 2022-02-24 | ||||||||||||
| 2019-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $807.00K derived: sum of 2 quarters · filed 2020-11-05 | -$785.00K 10-Q · filed 2020-11-05 | $636.00K derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||
| 2019-06-30 | $2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $515.00K 10-Q · filed 2020-08-06 | $1.94M derived: sum of 3 quarters · filed 2021-02-25 | $4.18M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||
| 2019-03-31 | -$1.59M 10-Q · filed 2020-05-05 | -$171.00K derived: sum of 2 quarters · filed 2021-02-25 | $2.08M derived: sum of 3 quarters · filed 2021-02-25 | $105.00K derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||
| 2018-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.67M derived: sum of 2 quarters · filed 2021-02-25 | $1.70M derived: sum of 3 quarters · filed 2021-02-25 | $2.06M 10-K · filed 2021-02-25 | ||||||||||||
| 2018-09-30 | $2.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $276.00K derived: sum of 2 quarters · filed 2019-11-04 | $644.00K 10-Q · filed 2019-11-04 | $199.00K derived: sum of 4 quarters · filed 2020-02-25 | ||||||||||||
| 2018-06-30 | -$1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$1.60M 10-Q · filed 2019-08-01 | -$2.05M derived: sum of 3 quarters · filed 2020-02-25 | -$471.00K derived: sum of 4 quarters · filed 2020-02-25 | ||||||||||||
| 2018-03-31 | $368.00K 10-Q · filed 2019-05-07 | -$77.00K derived: sum of 2 quarters · filed 2020-02-25 | $1.50M derived: sum of 3 quarters · filed 2020-02-25 | $2.52M derived: sum of 4 quarters · filed 2020-02-25 | ||||||||||||
| 2017-12-31 | -$445.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $1.13M derived: sum of 2 quarters · filed 2020-02-25 | $2.15M derived: sum of 3 quarters · filed 2020-02-25 | $4.51M 10-K · filed 2020-02-25 | $875.00K 10-K · filed 2018-03-12 | |||||||||||
| 2017-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $2.60M derived: sum of 2 quarters · filed 2018-11-06 | $4.95M 10-Q · filed 2018-11-06 | $6.72M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||||||
| 2017-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $3.38M 10-Q · filed 2018-08-07 | $5.14M derived: sum of 3 quarters · filed 2019-02-28 | $5.63M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||||||
| 2017-03-31 | $2.35M 10-Q · filed 2018-05-10 | $4.12M derived: sum of 2 quarters · filed 2019-02-28 | $4.61M derived: sum of 3 quarters · filed 2019-02-28 | $5.20M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||||||
| 2016-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $2.26M derived: sum of 2 quarters · filed 2019-02-28 | $2.85M derived: sum of 3 quarters · filed 2019-02-28 | $2.77M 10-K · filed 2019-02-28 | ||||||||||||
| 2016-09-30 | $492.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $1.08M derived: sum of 2 quarters · filed 2017-11-02 | $997.00K 10-Q · filed 2017-11-02 | $1.04M derived: sum of 4 quarters · filed 2018-03-12 | ||||||||||||
| 2016-06-30 | $589.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $505.00K 10-Q · filed 2017-08-03 | $553.00K derived: sum of 3 quarters · filed 2018-03-12 | $404.00K derived: sum of 4 quarters · filed 2018-03-12 | ||||||||||||
| 2016-03-31 | -$84.00K 10-Q · filed 2017-05-03 | -$36.00K derived: sum of 2 quarters · filed 2018-03-12 | -$185.00K derived: sum of 3 quarters · filed 2018-03-12 | $65.00K derived: sum of 4 quarters · filed 2018-03-12 | ||||||||||||
| 2015-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$101.00K derived: sum of 2 quarters · filed 2018-03-12 | $149.00K derived: sum of 3 quarters · filed 2018-03-12 | $211.00K 10-K · filed 2018-03-12 | ||||||||||||
| 2015-09-30 | -$149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $101.00K derived: sum of 2 quarters · filed 2016-11-04 | $163.00K 10-Q · filed 2016-11-04 | $179.00K 10-Q · filed 2015-11-06 | $173.00K derived: sum of 4 quarters · filed 2017-03-09 | |||||||||||
| 2015-06-30 | $250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $312.00K 10-Q · filed 2016-08-09 | $312.27K 10-Q · filed 2015-08-10 | $322.00K derived: sum of 3 quarters · filed 2017-03-09 | $298.51K derived: sum of 4 quarters · filed 2017-03-09 | |||||||||||
| 2015-03-31 | $62.00K 10-Q · filed 2016-05-09 | $62.75K 10-Q · filed 2015-05-11 | $72.00K derived: sum of 2 quarters · filed 2017-03-09 | $48.51K derived: sum of 3 quarters · filed 2017-03-09 | $3.63K derived: sum of 4 quarters · filed 2017-03-09 | |||||||||||
| 2014-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$13.49K derived: sum of 2 quarters · filed 2017-03-09 | -$58.38K derived: sum of 3 quarters · filed 2017-03-09 | -$108.00K 10-K · filed 2017-03-09 | -$107.58K 10-K · filed 2015-03-16 | |||||||||||
| 2014-09-30 | -$23.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$68.38K derived: sum of 2 quarters · filed 2015-11-06 | -$118.00K 10-Q · filed 2015-11-06 | -$132.57K 10-Q · filed 2014-11-13 | $44.40K derived: sum of 4 quarters · filed 2016-03-11 | |||||||||||
| 2014-06-30 | -$44.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$94.51K 10-Q · filed 2015-08-10 | $67.89K derived: sum of 3 quarters · filed 2016-03-11 | $67.63K derived: sum of 4 quarters · filed 2016-03-11 | ||||||||||||
| 2014-03-31 | -$49.63K 10-Q · filed 2015-05-11 | $49.63K 10-Q · filed 2014-05-14 | $112.77K derived: sum of 2 quarters · filed 2016-03-11 | $112.52K derived: sum of 3 quarters · filed 2016-03-11 | $115.25K derived: sum of 4 quarters · filed 2016-03-11 | -$124.09K 10-Q · filed 2014-05-14 | ||||||||||
| 2013-12-31 | $162.40K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $162.14K derived: sum of 2 quarters · filed 2016-03-11 | $164.88K derived: sum of 3 quarters · filed 2016-03-11 | $164.00K 10-K · filed 2016-03-11 | $166.44K 10-K · filed 2014-03-28 | $173.72K 10-K · filed 2014-03-28 | ||||||||||
| 2013-09-30 | -$257.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $2.48K derived: sum of 2 quarters · filed 2014-11-13 | $1.60K 10-Q · filed 2014-11-13 | $3.88K derived: sum of 4 quarters · filed 2014-11-13 | $8.88K 10-Q · filed 2013-11-14 | |||||||||||
| 2013-06-30 | $2.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $1.86K 10-Q · filed 2014-08-08 | $4.13K derived: sum of 3 quarters · filed 2014-08-08 | -$15.49K derived: sum of 4 quarters · filed 2014-08-08 | $9.13K 10-Q · filed 2013-10-23 | |||||||||||
| 2013-03-31 | -$875.00 10-Q · filed 2014-05-14 | $1.40K derived: sum of 2 quarters · filed 2014-05-14 | -$18.23K derived: sum of 3 quarters · filed 2014-05-14 | -$3.28K derived: sum of 4 quarters · filed 2014-05-14 | -$8.15K 10-Q · filed 2013-10-23 | |||||||||||
| 2012-12-31 | $2.27K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | -$17.35K derived: sum of 2 quarters · filed 2014-03-28 | -$2.40K derived: sum of 3 quarters · filed 2014-03-28 | -$22.59K 10-K · filed 2014-03-28 | $22.59K 10-K · filed 2013-09-23 | -$7.28K 10-K · filed 2013-09-23 | ||||||||||
| 2012-09-30 | -$19.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$4.68K derived: sum of 2 quarters · filed 2013-11-14 | -$24.86K 10-Q · filed 2013-11-14 | -$71.33K derived: sum of 4 quarters · filed 2013-11-14 | $5.00K 10-Q · filed 2013-01-25 | |||||||||||
| 2012-06-30 | $14.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-23 | -$5.24K 10-Q · filed 2013-10-23 | -$51.71K derived: sum of 3 quarters · filed 2013-10-23 | -$25.71K derived: sum of 4 quarters · filed 2013-10-23 | $24.63K 10-Q/A · filed 2012-09-10 | |||||||||||
| 2012-03-31 | -$20.19K 10-Q · filed 2013-10-23 | $20.19K 10-Q · filed 2012-05-15 | -$66.66K derived: sum of 2 quarters · filed 2013-10-23 | -$40.66K derived: sum of 3 quarters · filed 2013-10-23 | -$48.45K derived: sum of 4 quarters · filed 2013-10-23 | $50.05K 10-Q · filed 2012-05-15 | ||||||||||
| 2011-12-31 | -$46.47K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-23 | -$20.47K derived: sum of 2 quarters · filed 2013-09-23 | -$28.26K derived: sum of 3 quarters · filed 2013-09-23 | -$21.42K 10-K · filed 2013-09-23 | ||||||||||||
| 2011-09-30 | $26.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-01-25 | $18.21K derived: sum of 2 quarters · filed 2013-01-25 | $25.05K 10-Q · filed 2013-01-25 | |||||||||||||
| 2011-06-30 | -$7.79K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-10 | -$947.00 10-Q/A · filed 2012-09-10 | ||||||||||||||
| 2011-03-31 | $6.84K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |